Asset Details
Do you wish to reserve the book?
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
Do you wish to request the book?
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
2014
Overview
Patients with triple-negative breast cancer (TNBC) have a high incidence of early relapse and metastasis; however, the molecular basis for recurrence in these individuals remains poorly understood. Here, we demonstrate that RASAL2, which encodes a RAS-GTPase-activating protein (RAS-GAP), is a functional target of anti-invasive microRNA-203 and is overexpressed in a subset of triple-negative or estrogen receptor-negative (ER-negative) breast tumors. As opposed to luminal B ER-positive breast cancers, in which RASAL2 has been shown to act as a RAS-GAP tumor suppressor, we found that RASAL2 is oncogenic in TNBC and drives mesenchymal invasion and metastasis. Moreover, high RASAL2 expression was predictive of poor disease outcomes in patients with TNBC. RASAL2 acted independently of its RAS-GAP catalytic activity in TNBC; however, RASAL2 promoted small GTPase RAC1 signaling, which promotes mesenchymal invasion, through binding and antagonizing the RAC1-GAP protein ARHGAP24. Together, these results indicate that activation of a RASAL2/ARHGAP24/RAC1 module contributes to TNBC tumorigenesis and identify a context-dependent role of RASAL2 in breast cancer.
Publisher
American Society for Clinical Investigation
Subject
/ Biology
/ Breast Neoplasms - metabolism
/ Breast Neoplasms - pathology
/ Carrier Proteins - metabolism
/ Enzyme Activation - genetics
/ Female
/ Genes
/ Genomes
/ GTPase-Activating Proteins - genetics
/ GTPase-Activating Proteins - metabolism
/ Humans
/ Mice
/ MicroRNA
/ Neoplasm Proteins - genetics
/ Neoplasm Proteins - metabolism
/ Oncology
/ Proteins
/ rac1 GTP-Binding Protein - genetics
/ rac1 GTP-Binding Protein - metabolism
/ Rodents
/ Studies
/ Tumors
